Nordimed
Nordimed, officially known as Nordimed A/S, is a prominent player in the medical technology industry, headquartered in Denmark (DK). Founded in 2005, the company has established itself as a leader in providing innovative healthcare solutions across Europe and beyond. Specialising in advanced medical devices and diagnostic tools, Nordimed is recognised for its commitment to quality and precision. Their core products, which include state-of-the-art imaging systems and patient monitoring solutions, are designed to enhance clinical outcomes and streamline healthcare processes. With a strong market position, Nordimed has achieved significant milestones, including partnerships with leading healthcare institutions and a growing portfolio of patented technologies. The company continues to drive advancements in medical technology, ensuring that healthcare professionals have access to the best tools available.
DitchCarbon Score
How does Nordimed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nordimed's score of 24 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nordimed's reported carbon emissions
NordiMED, headquartered in Denmark, has set ambitious climate commitments despite not having specific carbon emissions data available. The company is dedicated to maintaining zero Scope 1 emissions through 2030, demonstrating a strong commitment to reducing its direct greenhouse gas emissions. Additionally, NordiMED aims to achieve a 42% reduction in absolute Scope 2 greenhouse gas emissions by 2030, using 2022 as the baseline year. These targets have been validated through the Science Based Targets initiative (SBTi), aligning with the necessary reductions to limit global warming to 1.5°C. Furthermore, NordiMED is committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions in its value chain. This comprehensive approach underscores NordiMED's dedication to sustainability and its proactive stance in addressing climate change within the professional services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nordimed is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
